The mucopolysaccharidoses

No abstract is available for this paper.

• Publication year

  2020

• Venue

  Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/b978-0-12-813955-4.00035-0
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Genotype‐phenotype relationships in mucopolysaccharidosis type I (MPS I): Insights from the International MPS I Registry

  2019cited by this paper
• Recommendations for the management of MPS IVA: systematic evidence- and consensus-based guidance

  2019cited by this paper
• Complex care of individuals with multiple sulfatase deficiency: Clinical cases and consensus statement.

  2018cited by this paper
• Worldwide distribution of common IDUA pathogenic variants

  2018cited by this paper
• Causal Therapies in Mucopolysaccharidoses: Enzyme Replacement Therapy

  2018cited by this paper
• Mucopolysaccharidosis Type I Newborn Screening: Best Practices for Diagnosis and Management.

  2017cited by this paper
• Gene therapy for Mucopolysaccharidoses.

  2017cited by this paper
• Clinical course of sly syndrome (mucopolysaccharidosis type VII)

  2016cited by this paper
• Molecular diagnosis of 65 families with mucopolysaccharidosis type II (Hunter syndrome) characterized by 16 novel mutations in the IDS gene: Genetic, pathological, and structural studies on iduronate-2-sulfatase.

  2016cited by this paper
• Enzyme replacement therapy prior to haematopoietic stem cell transplantation in Mucopolysaccharidosis Type I: 10 year combined experience of 2 centres.

  2016cited by this paper
• Screening Mucopolysaccharidosis Type IX in Patients with Juvenile Idiopathic Arthritis.

  2015cited by this paper
• Long-term outcome of Hurler syndrome patients after hematopoietic cell transplantation: an international multicenter study.

  2015cited by this paper
• Sanfilippo syndrome: Overall review

  2015cited by this paper
• Current and potential therapeutic strategies for mucopolysaccharidoses

  2014cited by this paper
• Animal Model of Human Disease : Mucopolysaccharidosis Type VII ( Sly Syndrome ) . Beta-Glucuronidase-Deficient Mucopolysaccharidosis in the Dog

  2013cited by this paper
• Enzyme replacement therapy with galsulfase in 34 children younger than five years of age with MPS VI.

  2013cited by this paper
• Up to five years experience with 11 mucopolysaccharidosis type VI patients.

  2013cited by this paper
• Mucopolysaccharidosis type VI phenotypes-genotypes and antibody response to galsulfase

  2013cited by this paper
• Molecular characterization of 355 mucopolysaccharidosis patients reveals 104 novel mutations

  2013cited by this paper
• Review of clinical presentation and diagnosis of mucopolysaccharidosis IVA.

  2013cited by this paper
• Murine Hyaluronidase 2 Deficiency Results in Extracellular Hyaluronan Accumulation and Severe Cardiopulmonary Dysfunction*

  2012cited by this paper
• Analysis of the IDS Gene in 38 Patients with Hunter Syndrome: The c.879G>A (p.Gln293Gln) Synonymous Variation in a Female Create Exonic Splicing

  2011cited by this paper
• Orthopaedic aspects of mucopolysaccharidoses.

  2011cited by this paper
• GM1 gangliosidosis and Morquio B disease: an update on genetic alterations and clinical findings.

  2011cited by this paper
• Molecular analysis of Sanfilippo syndrome type C in Spain: seven novel HGSNAT mutations and characterization of the mutant alleles

  2011cited by this paper
• A complete deficiency of Hyaluronoglucosaminidase 1 (HYAL1) presenting as familial juvenile idiopathic arthritis

  2011cited by this paper
• Mucopolysaccharidosis type IIIA: Clinical spectrum and genotype‐phenotype correlations

  2010cited by this paper
• Long-term Efficacy and Safety of Laronidase in the Treatment of Mucopolysaccharidosis I

  2009cited by this paper
• Identification of the gene encoding the enzyme deficient in mucopolysaccharidosis IIIC (Sanfilippo disease type C).

  2006cited by this paper
• Über einen Typ multipler Abartungen, vorwiegend am Skelettsystem

  2005cited by this paper
• OCCURRENCE OF URINARY ACID MI UCOPOLYSACCHARIDES IN THE HURLER SYNDROMIE*

  2004cited by this paper
• Founder Mutation R245H of Sanfilippo Syndrome Type A in the Cayman Islands

  2002cited by this paper
• Mutation 1091delC is highly prevalent in Spanish Sanfilippo syndrome type A patients

  1998cited by this paper
• NAGLU mutations underlying Sanfilippo syndrome type B.

  1998cited by this paper
• Identification of molecular defects in Italian Sanfilippo A patients including 13 novel mutations

  1998cited by this paper
• Genotype-phenotype correspondence in Sanfilippo syndrome type B.

  1998cited by this paper
• Molecular heterogeneity in mucopolysaccharidosis IVA in Australia and Northern Ireland: Nine novel mutations including T312S, a common allele that confers a mild phenotype

  1998cited by this paper
• Novel mutations in Sanfilippo A syndrome: implications for enzyme function.

  1997cited by this paper
• Identification of 31 novel mutations in the N‐acetylgalactosamine‐6‐sulfatase gene reveals excessive allelic heterogeneity among patients with Morquio A syndrome

  1997cited by this paper
• Identification of 16 sulfamidase gene mutations including the common R74C in patients with mucopolysaccharidosis type IIIA (Sanfilippo A)

  1997cited by this paper
• Fragile X syndrome in two siblings with major congenital malformations.

  1996cited by this paper
• Cloning and expression of the gene involved in Sanfilippo B syndrome (mucopolysaccharidosis III B).

  1996cited by this paper
• Clinical and biochemical manifestations of hyaluronidase deficiency.

  1996cited by this paper
• Mucopolysaccharidosis IVA (Morquio A): Three novel small deletions in the N‐acetylgalactosamine‐6‐sulfate sulfatase gene

  1996cited by this paper
• Mucopolysaccharidosis IVA: Submicroscopic deletion of 16q24.3 and a novel R386C mutation of n‐acetylgalactosamine‐6‐sulfate sulfatase gene in a classical Morquio disease

  1996cited by this paper
• The molecular basis of Sanfilippo syndrome type B.

  1996cited by this paper
• Cloning of the sulphamidase gene and identification of mutations in Sanfilippo A syndrome

  1995cited by this paper
• Mucopolysaccharidosis IVA: identification of a common missense mutation I113F in the N-Acetylgalactosamine-6-sulfate sulfatase gene.

  1995cited by this paper
• Two new mutations, Q473X and N487S, in a caucasian patient with mucopolysaccharidosis IVA (Morquio disease)

  1995cited by this paper
• Mucopolysaccharidosis type IVA: identification of six novel mutations among non-Japanese patients

  1995cited by this paper
• Mucopolysaccharidosis IVA: screening and identification of mutations of the N-acetylgalactosamine-6-sulfate sulfatase gene.

  1995cited by this paper
• Mucopolysaccharidosis IVA: structural gene alterations identified by Southern blot analysis and identification of racial differences

  1995cited by this paper
• Four novel mutations in mucopolysaccharidosis type VII including a unique base substitution in exon 10 of the beta-glucuronidase gene that creates a novel 5'-splice site.

  1995cited by this paper
• Intracellular processing and maturation of mutant gene products in hereditary β-galactosidase deficiency (β-galactosidosis)

  1994cited by this paper
• Molecular analysis by Southern blot for theN-acetylgalactosamine-6-sulphate sulphatase gene causing mucopolysaccharidosis IVA in the Japanese population

  1994cited by this paper
• Feline Mucopolysaccharidosis VII Due to β-glucuronidase Deficiency

  1994cited by this paper
• Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): six unique arylsulfatase B gene alleles causing variable disease phenotypes.

  1994cited by this paper
• Sanfilippo Type D Presenting With Acquired Language Disorder but Without Features of Mucopolysaccharidosis

  1994cited by this paper
• Mutations of the iduronate‐2‐sulfatase (IDS) gene in patients with hunter syndrome (mucopolysaccharidosis II)

  1994cited by this paper
• Four novel mutant alleles of the arylsulfatase B gene in two patients with intermediate form of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)

  1994cited by this paper
• Mucopolysaccharidosis type I: identification of 8 novel mutations and determination of the frequency of the two common alpha-L-iduronidase mutations (W402X and Q70X) among European patients.

  1994cited by this paper
• Mutation analysis of 19 North American mucopolysaccharidosis type I patients: Identification of two additional frequent mutations

  1994cited by this paper
• Mucopolysaccharidosis IV A: molecular cloning of the human N-acetylgalactosamine-6-sulfatase gene (GALNS) and analysis of the 5'-flanking region.

  1994cited by this paper
• A novel splice site mutation in intron 1 of the GALNS gene in a Japanese patient with mucopolysaccharidosis IVA.

  1994cited by this paper
• Morquio A syndrome: cloning, sequence, and structure of the human N-acetylgalactosamine 6-sulfatase (GALNS) gene.

  1994cited by this paper
• A mutant stop codon (TAG) in the IDUA gene is used as an acceptor splice site in a patient with Hurler syndrome (MPS IH)

  1994cited by this paper
• The morquio A syndrome (mucopolysaccharidosis IVA) gene maps to 16q24.3.

  1993cited by this paper
• Carrier detection of Hunter syndrome (MPS II) by biochemical and DNA techniques in families at risk.

  1993cited by this paper
• Mutational analysis of a patient with mucopolysaccharidosis type VII, and identification of pseudogenes.

  1993cited by this paper
• Determination of the organisation of coding sequences within the iduronate sulphate sulphatase (IDS) gene.

  1993cited by this paper
• Identification of mutations in the alpha-L-iduronidase gene (IDUA) that cause Hurler and Scheie syndromes.

  1993cited by this paper
• Mutational studies in a patient with the hydrops fetalis form of mucopolysaccharidosis type VII

  1993cited by this paper
• Mucopolysaccharidosis IV A: assignment of the human N-acetylgalactosamine-6-sulfate sulfatase (GALNS) gene to chromosome 16q24.

  1993cited by this paper
• An N‐acetylgalactosamine‐4‐sulfatase mutation (ΔG238) results in a severe Maroteaux‐Lamy phenotype

  1992cited by this paper
• Structural gene aberrations in mucopolysaccharidosis II (Hunter)

  1992cited by this paper
• Mucopolysaccharidosis type IVA. N-acetylgalactosamine-6-sulfate sulfatase exonic point mutations in classical Morquio and mild cases.

  1992cited by this paper
• α‐L‐iduronidase mutations (Q70X and P533R) associate with a severe Hurler phenotype

  1992cited by this paper
• A common mutation for mucopolysaccharidosis type I associated with a severe Hurler syndrome phenotype

  1992cited by this paper
• Gene diagnosis and carrier detection in hunter syndrome by the iduronate-2-sulphatase cDNA probe

  1992cited by this paper
• Mucopolysaccharidosis type VI: identification of three mutations in the arylsulfatase B gene of patients with the severe and mild phenotypes provides molecular evidence for genetic heterogeneity.

  1992cited by this paper
• The iduronate sulfatase gene: isolation of a 1.2-Mb YAC contig spanning the entire gene and identification of heterogeneous deletions in patients with Hunter syndrome.

  1992cited by this paper
• Multiple sulfatase deficiency: catalytically inactive sulfatases are expressed from retrovirally introduced sulfatase cDNAs.

  1992cited by this paper
• Structure and sequence of the human α-l-iduronidase gene

  1992cited by this paper
• Feline arylsulfatase B (ARSB): isolation and expression of the cDNA, comparison with human ARSB, and gene localization to feline chromosome A1.

  1992cited by this paper
• Morquio disease: isolation, characterization and expression of full-length cDNA for human N-acetylgalactosamine-6-sulfate sulfatase.

  1991cited by this paper
• Mucopolysaccharidosis type VII: characterization of mutations and molecular heterogeneity.

  1991cited by this paper
• Human alpha-L-iduronidase: cDNA isolation and expression.

  1991cited by this paper
• The clinical phenotype of two patients with a complete deletion of the iduronate-2-sulphatase gene (mucopolysaccharidosis II — Hunter syndrome)

  1991cited by this paper
• Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). An intermediate clinical phenotype caused by substitution of valine for glycine at position 137 of arylsulfatase B.

  1991cited by this paper
• Hunter disease (mucopolysaccharidosis type II) associated with unbalanced inactivation of the X chromosomes in a karyotypically normal girl.

  1991cited by this paper
• Frequent deletions at Xq28 indicate genetic heterogeneity in Hunter syndrome

  1991cited by this paper
• Huntington disease-linked locusD4S111 exposed as the α-l-iduronidase gene

  1991cited by this paper
• Molecular basis of mucopolysaccharidosis type VII: replacement of Ala619 in beta-glucuronidase with Val.

  1990cited by this paper
• Human arylsulfatase B: MOPAC cloning, nucleotide sequence of a full-length cDNA, and regions of amino acid identity with arylsulfatases A and C.

  1990cited by this paper
• Hunter syndrome: isolation of an iduronate-2-sulfatase cDNA clone and analysis of patient DNA.

  1990cited by this paper
• Phylogenetic conservation of arylsulfatases. cDNA cloning and expression of human arylsulfatase B.

  1990cited by this paper
• Chromosomal localization of the human alpha-L-iduronidase gene (IDUA) to 4p16.3.

  1990cited by this paper
• Cloning and characterization of the human beta-glucuronidase gene.

  1990cited by this paper
• Chromosomal localization of ARSB, the gene for human N-acetylgalactosamine-4-sulphatase

  1989cited by this paper
• Use of antisense RNA to help identify a genomic clone for the 5' region of mouse beta-glucuronidase.

  1989cited by this paper

• No citing papers are available for this paper.